Literature DB >> 12411331

Treating acute gouty arthritis with selective COX 2 inhibitors.

Adel G Fam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411331      PMCID: PMC1124536          DOI: 10.1136/bmj.325.7371.980

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?

Authors:  M Feldman; A T McMahon
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

2.  Nomenclature for COX-2 inhibitors.

Authors:  J R Vane; T D Warner
Journal:  Lancet       Date:  2000-10-21       Impact factor: 79.321

3.  Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes.

Authors:  M Pouliot; M J James; S R McColl; P H Naccache; L G Cleland
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

Review 4.  Therapeutic potential of COX-2 inhibitors in arthritis.

Authors:  C G Jackson
Journal:  Expert Opin Investig Drugs       Date:  2001-07       Impact factor: 6.206

5.  Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

Authors:  D Riendeau; M D Percival; C Brideau; S Charleson; D Dubé; D Ethier; J P Falgueyret; R W Friesen; R Gordon; G Greig; J Guay; J Mancini; M Ouellet; E Wong; L Xu; S Boyce; D Visco; Y Girard; P Prasit; R Zamboni; I W Rodger; M Gresser; A W Ford-Hutchinson; R N Young; C C Chan
Journal:  J Pharmacol Exp Ther       Date:  2001-02       Impact factor: 4.030

6.  Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.

Authors:  H Ralph Schumacher; Judith A Boice; David I Daikh; Saurabh Mukhopadhyay; Kerstin Malmstrom; Jennifer Ng; Guillermo A Tate; Javier Molina
Journal:  BMJ       Date:  2002-06-22

7.  Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Authors:  J L Masferrer; B S Zweifel; P T Manning; S D Hauser; K M Leahy; W G Smith; P C Isakson; K Seibert
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

  7 in total
  5 in total

1.  Colchicine in acute gout.

Authors:  Ian Morris; George Varughese; Peter Mattingly
Journal:  BMJ       Date:  2003-11-29

Review 2.  Persisting eicosanoid pathways in rheumatic diseases.

Authors:  Marina Korotkova; Per-Johan Jakobsson
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

3.  Zisheng Shenqi decoction ameliorates monosodium urate crystal-induced gouty arthritis in rats through anti-inflammatory and anti-oxidative effects.

Authors:  Jieru Han; Ying Xie; Fangyu Sui; Chunhong Liu; Xiaowei Du; Chenggang Liu; Xiaoling Feng; Deyou Jiang
Journal:  Mol Med Rep       Date:  2016-07-18       Impact factor: 2.952

4.  Anti‑gouty arthritis and anti‑hyperuricemia properties of celery seed extracts in rodent models.

Authors:  Shaopeng Li; Lanzhou Li; Han Yan; Xue Jiang; Weiwei Hu; Ning Han; Di Wang
Journal:  Mol Med Rep       Date:  2019-09-26       Impact factor: 2.952

Review 5.  Identification of Active Compounds From Yi Nationality Herbal Formula Wosi Influencing COX-2 and VCAM-1 Signaling.

Authors:  Ji-Zhong Zhang; Xiao-Yi Chen; You-Jiao Wu; Li-Min Li; Li Huang; Qiao-Zhi Yin; Pei Luo; Yuan Liu
Journal:  Front Pharmacol       Date:  2020-11-09       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.